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ABSTRACT 
Di-(2-ethylhexyl) phthalate (DEHP) is a plasticizer that is often found in polyvinyl chloride 
products such as shower curtains, swimming pool liners, rain coats, car upholstery, wire 
sheathing, baby toys, garden hoses, tablecloths, wall coverings, medical tubing, and blood 
transfusion bags.  DEHP can readily leach from products into the environment.  This is of 
concern because DEHP exhibits endocrine disrupting activity and is a known testicular toxicant. 
While the effects of DEHP on the testes are well documented, little is known about the effects of 
DEHP on the ovary and female reproduction.  Thus, I tested the hypothesis that prenatal DEHP 
exposure adversely affects ovarian development and reproductive outcomes in the female 
offspring of mice.   To test this hypothesis, timed pregnant female CD-1 mice were orally dosed 
daily with tocopherol-stripped corn oil (vehicle control), 20µg/kg/day, 200µg/kg/day, 
200mg/kg/day, 500mg/kg/day, or 750mg/kg/day DEHP from gestation day (GD) 11 until birth of 
the pups.  On postnatal day (PND) 0, pups were counted, weighed, and sexed.  On PNDs 1, 8, 
21, and 60, at least 1 female pup from each litter was euthanized and her ovaries were harvested.  
At PND 8 and 21, one collected ovary from each pup was subjected to histological evaluation of 
primordial, primary, preantral, and antral follicle numbers.  On PND 21, at least one pup from 
each litter was weaned and subjected to daily vaginal smears to monitor estrous cyclicity.  When 
the females were three months old they were bred to proven-breeder males to evaluate their 
fertility based on whether the females became pregnant, time to pregnancy, and numbers of pups 
born.   The results indicate that prenatal DEHP exposure did not significantly affect the numbers 
of pups born in each litter or their weights at birth, but does alter the male-to-female ratio in each 
litter.  At PND 8, liver weight was significantly reduced in the 200mg/kg/day exposed animals 
compared to controls.  At PND 21 and 60, uterine weight was significantly increased in animals 
exposed to 200µg/kg/day and 750mg/kg/day, respectively compared to controls.  At PND 21, 
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ovarian weight was significantly reduced in animals exposed to 20µg/kg/day compared to 
controls.  At PND 21, prenatal DEHP exposure did not alter estrous cyclicity compared to 
controls.  At PND 8, numbers of ovarian follicles were not significantly affected, however, at 
PND 21, numbers of preantral follicles were significantly increased in mice exposed to 
200µg/kg/day and 500mg/kg/day DEHP in utero compared to controls.  Interestingly, 60% of 
500mg/kg/day treated animals were unable to become pregnant at three months of age and 
several DEHP treated animals took longer than 5 days to become pregnant and lost their pups.  
Collectively, these data suggest that prenatal exposure to DEHP may not affect the numbers or 
weights of pups at birth, pubertal onset, estrous cyclicity, or the numbers of follicles present in 
the ovary on PND 8.  However, prenatal DEHP exposure does alter F1 sex-ratio, reduce liver 
weight at PND 8, increase uterine weight at PND 21, reduce ovarian weight at PND 21, and 
increase numbers of preantral follicles in PND 21 ovaries in mouse offspring.  Further, prenatal 
DEHP exposure may cause breeding abnormalities. 
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CHAPTER 1 
INTRODUCTION 
 
Female reproductive capacity is determined at birth.  Mammals are born with a finite 
pool of primordial follicles, which is established during development in utero.  These follicles 
will either undergo multiple stages of development until reaching the antral stage when they can 
be ovulated and be fertilized, or they will be lost to atresia.  Reproductive senescence occurs 
when the follicular reserve is depleted [1].  Exposure to chemicals, especially endocrine 
disrupting chemicals (EDCs), can accelerate the process of reproductive senescence by rapidly 
depleting the follicle pool.   
Ovarian follicles are not only necessary for fertility, but also for the production of sex 
steroid hormones.  These steroid hormones are important for reproductive, cardiovascular, brain, 
and bone health.  Without ovarian follicles, sex steroid hormone production would be 
significantly reduced, and the aforementioned body systems could be negatively affected [2].  
Many EDCs can disrupt sex steroid hormone production by altering folliculogenesis or by 
binding to hormone receptors and acting as agonists or antagonists.   
EDCs alter folliculogenesis by targeting follicles at a specific stage of follicular 
development.  Chemicals that target germ cells or primordial follicles can cause complete and 
irreversible infertility because these follicles would never reach the antral stage required for 
ovulation.  Chemicals that target primary and preantral follicles may result in latent subfertility 
around the period of exposure because these follicles would not reach the antral stage and be 
ovulated and fertilized; however, removal of the chemical could allow fertility to be restored if 
enough time elapses for undamaged primordial follicles to grow to the antral stage.  Chemicals 
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that target antral follicles could result in complete infertility at the time of exposure, but removal 
of the chemical could allow complete restoration of fertility if primordial, primary, and preantral 
follicles were not damaged by the chemical exposure.  Antral follicles are the only follicles 
capable of synthesizing sex steroid hormones, so any chemical that affects the number of antral 
follicles, whether directly or indirectly by targeting follicles in earlier stages of development, 
will affect sex steroid hormone levels [3].  In addition to fertility being affected, changes in sex 
steroid hormone production can affect estrous/menstrual cyclicity, reproductive organ 
morphology, and pubertal onset [4].   
Phthalates are a class of chemicals found in wide range of consumer, medical, and 
building materials and products.  Di-(2-ethylkexyl) phthalate (DEHP) is a plasticizing agent 
commonly found in polyvinyl chloride (PVC) products such as shower curtain liners, car 
upholstery, baby toys, wire sheathing, synthetic wall coverings, medical tubing, and IV and 
blood transfusion bags.  DEHP is not covalently bonded to the polymers of these products and, 
as a result, readily leaches from these products into the environment, making it an environmental 
toxicant.   
Because of the quantity and variety of products containing DEHP, exposure can occur via 
oral ingestion, inhalation, dermal contact, and intravenously through medical procedures.  DEHP 
and its metabolites have been identified in a number of human tissues and fluids including urine, 
serum, cord blood, breast milk, amniotic fluid, and ovarian follicular fluid [5, 6].  The presence 
of DEHP in follicular fluid indicates its ability to reach the ovary, and its presence in amniotic 
fluid and cord blood implies it is able to reach the fetus.  The Agency for Toxic Substances and 
Disease Registry estimates that humans are exposed daily to DEHP between 3-30 µg/kg/day [7, 
8].   
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Human exposure to DEHP is a major concern because it is a known endocrine disrupting 
chemical and a reproductive toxicant.  Epidemiological studies have associated in utero exposure 
to DEHP with reduced anogenital distance (AGD) and testosterone levels in males, and 
experiments in rodent models have corroborated these findings [9, 10].  Additionally, 
epidemiological studies have reported correlations between prenatal exposure to DEHP and 
endometriosis, precocious puberty, early pregnancy loss, preterm birth, and low birth weight in 
humans, though these findings have been inconsistent [11, 12].   
EDC activity can be mediated through a variety of pathways.  Recent studies have shown 
that DEHP, through its bioactive metabolite mono-(2-ethylhexyl) phthalate (MEHP), may alter 
peroxisome proliferator-activated receptor (PPAR) downstream activity in a number of tissues.  
PPARs exist in three different isoforms: α, β, and γ.  The receptors are located in adipose tissue 
[13], liver cells [14], uterine endometrial cells [15], and throughout the ovary [16].  Changes in 
activity of PPARs in these tissues could result in dramatic effects.       
Effects caused by exposure to DEHP have been extensively researched in rodent models, 
through a variety of exposure windows and concentrations.  However, most previous studies 
have focused on males and, thus, not much is known about the effects of prenatal exposure to 
DEHP on female reproduction.  Further, few studies have been conducted using a wide range of 
doses of DEHP during a critical period of ovarian development and few studies have focused on 
the impact of prenatal DEHP exposure on ovarian development and future fertility of the female 
offspring.  If DEHP is truly an endocrine disrupting chemical and a reproductive toxicant, then 
prenatal exposure to the chemical could have extensive and irreversible adverse effects on the 
reproductive development and fertility of the female offspring.  Thus, this project was designed 
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to test the hypothesis that prenatal DEHP exposure adversely affects ovarian development and 
reproductive outcomes in the female offspring of mice.      
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Materials and Methods: 
Chemicals 
DEHP (99% purity) was purchased from Sigma-Aldrich (St. Louis, MO). Stock solutions of 
DEHP were prepared by diluting the chemical in tocopherol-stripped corn oil (MP Biomedicals, 
Solon, OH) to achieve the desired concentrations. 
Animals 
Adult cycling female outbred CD-1 mice (8 weeks old) were housed at 25°C in conventional 
polystyrene cages on 12L:12D cycles. The mice were provided Teklad Rodent Diet 8604 
(Harlan) and high purity water (reverse osmosis filtered) in glass water bottles ad libitum. All 
animal procedures were approved by the University of Illinois Institutional Animal Care and Use 
Committee.  Male CD-1 mice (8 weeks old) were housed with females during breeding (2 
females and 1 male per cage). 
Breeding Protocol 
At 8 weeks of age, 50 female mice (F0) were mated with control males of the same age. Mating 
was confirmed by the presence of vaginal plug and body weight gain. The day the vaginal plug 
was detected was defined as gestation day (GD) 1. Once the vaginal plug was observed, females 
were removed from males and individually caged.  
Dosing Regimen 
Previous studies have shown that DEHP appears to have a non-monotonic dose-response curve 
[17] so I elected to test a wide range of doses in my studies.  Each female was randomly assigned 
to one of 6 treatment groups: control, 20µg/kg/day, 200µg/kg/day, 200mg/kg/day, 
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500mg/kg/day, or 750mg/kg/day).  The lowest dose, 20µg/kg/day, was selected because it is the 
EPA reference dose for humans.  The 200µg/kg/day, 200mg/kg/day, and 750mg/kg/day doses 
were selected because they have been shown to have detrimental effects on primordial follicle 
recruitment in adult mice [18]. The 500mg/kg/day dose was selected because it  has adverse 
effects in male mice, including abnormal seminiferous tubule formation, decreased sperm count 
and motility, impaired stem cell function, decreased nipple retention, decreased anogenital 
distance, and delayed pubertal onset following prenatal exposure [19].   
From GD 11 until birth of the pups, dams were orally dosed once a day with tocopherol-stripped 
corn oil (vehicle control) or the assigned dose of DEHP by placing a pipette tip containing the 
dosing solution into the mouth.  GD 11 until birth was selected as the exposure window because 
this is a critical time period of ovarian development [20]. 
Tissue collection (F1) 
After delivery, on post-natal day (PND) 0, the numbers of pups, numbers of males and females, 
and numbers of dead pups (if any) were counted.  The average birth weights of the pups were 
determined by measuring weights of all live pups in the litter combined, and dividing the total 
weight by the total number of live pups in the litter.  On PND 1 (9-16 females per treatment 
group) and PND 8 (5-8 females per treatment group), females were euthanized by decapitation 
and blood was collected by exsanguination.  Both ovaries, both uterine horns, and the livers were 
harvested for analysis.  One ovary, one uterine horn, and one piece of liver were fixed in Dietrich 
fixative for histological evaluation.  The other ovary, uterine horn, and another piece of liver 
were snap-frozen in liquid nitrogen and stored at -80°C for future analysis of gene expression.  
When pups were about 21 days old (4-16 females per treatment group) and 60 days old (2-15 
females per treatment group), they were euthanized via carbon dioxide asphyxiation and blood 
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was collected by exsanguination. Both ovaries, uterine horns, and the liver were harvested as was 
done for PND 1 and PND 8 pups. Serum was isolated from the whole blood at each of the 
collections to be used for future measurements of hormone concentrations using enzyme-linked 
immunosorbent assays (ELISAs).  Additionally, at the PND 21 tissue collection, the distance 
between the anal and vaginal openings was measured to obtain anogenital distance (AGD). 
Body and Organ Weight Analysis (F1) 
At each of the tissue collections, the pups were weighed prior to euthanasia and organs were 
aseptically removed, cleaned of interstitial tissue, and weighed. Organ weights were recorded as 
whole organ weights and organ weights relative to body weights. Relative organ weights were 
calculated by dividing the weight of the organ by the body weight at the time of euthanasia and 
multiplying that value by 100.  This elicited each organ weight as a percent of body weight.  
Average body weights for each treatment group at PND 1, 8, 21, 60, 3 months, and 6 months 
were recorded and compared to control weights at each age.  Pre-pubertal weight gain was 
expressed as difference in raw weight between PND 0 and PND 21.  Post-pubertal weight gain 
was expressed as difference in raw weight between PND 21 and 6 months.   
Analysis of Estrous Cyclicity (F1) 
After weaning at PND 21, at least one F1 female from each litter was selected for examination of 
puberty onset and estrous cyclicity. These mice were weighed and checked for vaginal opening 
daily. Once vaginal opening occurred, estrous cyclicity was evaluated by examining vaginal 
smears daily for 30 days. The first observed estrus and the percentage of time that F1 females 
remained in each stage of the estrous cycle were calculated and reported.  A mouse was 
considered to be in proestrus if a majority of cells in the vaginal smear were nucleated epithelial 
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cells.  A mouse was considered to be in estrus if an overwhelming majority of the cells observed 
in the vaginal smear were cornified epithelial cells.  A mouse was considered to be in metestrus 
if the cells present were a mixture of cornified epithelial cells and a large number of leukocytes.  
A mouse was considered to be in diestrus when all cells present were leukocytes, or mostly 
leukocytes with a small number of nucleated epithelial cells.  Metestrus and diestrus were 
combined during analysis because these two stages are very similar in cytology and hormone 
profile.  Approximately four weeks prior to the six month breeding, F1 females to be bred had 
their estrous cyclicity monitored daily for 10 days, and the percent of time spent in each stage 
was calculated as previously mentioned.   
Histological evaluation of ovaries (F1) 
The ovaries from F1 females on PND 8 and 21 were collected and fixed in Dietrich fixative. The 
fixed tissues were embedded in paraffin, serially sectioned (8 μm), mounted on glass slides, and 
stained with Weigert's hematoxylin and picric acid–methyl blue. Every 10th section of the ovary 
was used to evaluate ovarian development by counting the numbers of primordial follicles, 
primary follicles, preantral follicles, and antral follicles.  All sections were evaluated without 
knowing the treatment group. Follicles were classified based on the following criteria: primordial 
follicles contained an oocyte surrounded by a single layer of squamous granulosa cells, primary 
follicles contained an oocyte surrounded by a single layer of cuboidal granulosa cells, preantral 
follicles contained an oocyte surrounded by at least two layers of cuboidal granulosa cells and 
theca cell layers, and antral follicles contained an oocyte surrounded by multiple layers of 
cuboidal granulosa cells with a fluid-filled antral space and theca cell layers. All primordial and 
primary follicles with oocytes, regardless of nuclear material in the oocytes, were counted, 
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whereas only preantral and antral follicles with a clear nucleus in the oocyte were counted to 
avoid redundant counting of follicles large enough to span multiple sections [20]. 
Analysis of Fertility (F1) 
At least four F1 females from each treatment group were selected to examine fertility at the age 
of three months. In each fertility test, the selected F1 females were first subjected to daily vaginal 
smears for two weeks to evaluate estrous cyclicity and then they were mated with fertility 
confirmed untreated males for two weeks or until a vaginal plug was observed. During mating, 
all the females were weighed twice weekly to monitor pregnancy weight gain. Once a vaginal 
plug was observed, females were weighed and individually caged. Litter sizes, average pup 
weights, sex ratios, and percent of dead pups were recorded on PND 0. After the two-week 
mating period, females who did not become pregnant were singly housed and kept alone until the 
next breeding time point.  Various breeding anomalies and complications were also recorded (i.e. 
number of dead pups, time between pairing and pregnancy, lack of pregnancy after two weeks 
with a male).  
Statistical analyses 
All data were analyzed using the F0 dam as the experimental unit (n).  Data from multiple F1 
females from the same litter were averaged and combined as n = 1.  For all analyses, data were 
expressed as means ± standard error of the means (SEM) from at least 4 different F0 litters. One-
way ANOVA followed by LSD and Dunnett t (2-sided) post hoc comparisons was used to make 
multiple comparisons between treatment groups.  If data had unequal variances according to 
Levene, Brown-Forsythe, or Welch tests, Games-Howell and Dunnett T3 post hoc comparisons 
were performed to compare treatment groups. If the data did not have a normal distribution 
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according to Shapiro-Wilk analysis, the data from each treatment group were compared using 
Mann-Whitney and Kruskal-Wallis tests. Statistical significance was assigned at p ≤ 0.05 for all 
comparisons. 
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Results: 
 
Effect of DEHP on F0 Fertility Outcomes 
 To determine if there were any effects on F0 fertility outcomes from exposure to DEHP 
from GD 11 until birth, F1 litters were analyzed for number of live pups born (Figure 1), birth 
weight (Figure 2), anogenital distance (Figure 3), and sex ratio (Figure 4).  Based on the data, 
there was no statistically significant difference in the number of live pups born, birth weight, or 
anogenital distance in treated litters when compared to controls.  However, there was a 
statistically significant increase in the ratio of males to females in litters treated with 200µg 
DEHP/kg/day during pregnancy compared to controls (n = 5-15 dams/treatment group; p≤0.05). 
   
Effect of DEHP on Body and Organ Weights 
 F1 females were weighed at birth (PND 0), PND 1 (Figure 5A), PND 8 (Figure 5B), PND 
21 (Figure 5C), PND 60 (Figure 6A), 3 months (Figure 6B), and 6 months (Figure 6C).  Weights 
at each age were compared between treatment groups; further, overall pre-pubertal (Figure 5D) 
and post-pubertal (Figure 6D) growth were compared among treatment groups.  At PND 8 and 
PND 60, 200mg/kg/day and 750mg/kg/day DEHP decreased weight compared to controls, 
respectively.  DEHP exposure did not significantly affect any other raw weights or comparisons 
of overall growth compared to controls.  Further, DEHP exposure did not affect pre-pubertal or 
post-pubertal weight gain compared to controls.     
 F1 female livers were weighed at PND 1 (Figure 7A), PND 8 (Figure 7B), PND 21 
(Figure 7C), and PND 60 (Figure 7D) when females were euthanized for tissue collection.   At 
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PND 8, liver weight was significantly reduced in the 200mg/kg/day treated animals, and was 
reduced, though not significantly, in the 500 mg/kg/day and 750mg/kg/day exposed animals 
compared to controls.   
 F1 uterine horns were weighed at PND 8 (Figure 8A), PND 21 (Figure 8B), and PND 60 
(Figure 8C) when females were euthanized for tissue collection.  At PND 8, DEHP did not 
significantly affect uterine weight, but at PND 21 and PND 60, DEHP exposure significantly 
increased uterine weight compared to controls at the 200µg/kg/day and at 750mg/kg/day doses 
compared to controls, respectively.   
F1 ovaries were weighed at PND 21 (Figure 9A) and PND 60 (Figure 9B) when females 
were euthanized for tissue collection.  At PND 21, DEHP exposure significantly decreased 
ovarian weight in mice exposed to 20µg/kg/day in utero compared to controls.  In contrast, at 
PND 60, DEHP exposure did not significantly affect ovarian weight compared to controls. 
 
Effect of DEHP on Pubertal Outcomes 
 The age at vaginal opening (Figure 10A), weight at vaginal opening (Figure 10B), and 
age at first estrus (Figure 10C) were recorded as indicators of pubertal onset.  DEHP exposure 
did not significantly affect any of these markers of puberty compared to controls.  Further, 
estrous cyclicity for 30 days after vaginal opening as well as average cycle length (Figures 11A 
and 11B, respectively) were not significantly different for any treatment group compared to 
control animals.   
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Effect of DEHP on Ovarian Morphology 
 At PND 8, the main follicle types present in the ovary are primordial, primary, and 
preantral, with an occasional follicle in the early antral stage (Figure 12A and 12B).  DEHP 
exposure did not have a significant effect on numbers of any type of follicle (primordial, 
primary, preantral, antral) in PND 8 ovaries (Figure 13A). 
PND 21 ovaries normally contain primordial, primary, preantral, and antral follicles.  At 
PND21, prenatal exposure to DEHP at the 200µg/kg/day and 500mg/kg/day doses significantly 
increased the number of preantral follicles compared to controls (Figure 13B).  Interestingly, 
DEHP exposure also led to the development of abnormal follicles based on the presence of 
apoptotic bodies (Figure 14A) and unhealthy oocytes (Figure 14B).   
 
Effect of DEHP on Fertility Outcomes of F1 offspring  
 Prenatal DEHP exposure did not significantly affect the days between mating and 
presence of vaginal plug (Figure 15A), number of F2 pups per litter (Figure 15B), or F2 birth 
weight (Figure 15C) compared to controls.  Unlike what we observed in the F1 litters (Figure 4), 
DEHP exposure did not significantly affect male to female ratio in the F2 litters (Figure 15D).   
Interestingly, prenatal DEHP exposure increased the percentage of F1 dams with 
breeding complications compared to controls (Figure 16).  For example, only 7% of control dams 
never got pregnant, but 25% of dams exposed to 20µg/kg/day never got pregnant, 33% of dams 
exposed to 200µg/kg/day never got pregnant, 60% of dams exposed to 500mg/kg/day never got 
pregnant, and 14% of dams treated with 750mg/kg/day never got pregnant.  Further, none of the 
control dams took longer than 5 days to get pregnant, whereas between 17-25% of the dams 
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exposed to 20µg/kg/day – 500mg/kg/day DEHP took longer than 5 days to get pregnant.  Finally, 
only 7% of control dams lost pups, whereas 14% of dams treated with 750mg/kg/day DEHP lost 
two pups or less, and 29% of dams treated with 750mg/kg/day lost all their pups. 
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Discussion: 
 The purpose of this study was to evaluate the effects of prenatal exposure to the 
plasticizer DEHP on ovarian development and female reproductive function.  Previous studies 
examining prenatal exposure to DEHP in humans and rodents have shown that DEHP is a 
reproductive toxicant that affects males, specifically by altering reproductive tract development 
and sexual differentiation [21].    A similar study performed by Grande et al. determined that  
DEHP exposure causes atresia in tertiary follicles in adult rats following perinatal and lactational 
exposure to DEHP until weaning, but no other effects of DEHP exposure were reported in that 
study [22].   
Our data indicate that prenatal exposure to 200µg DEHP/kg/day during ovarian 
development increases the ratio of males to females in F1 litters.  Since dosing began after sex 
was already determined, we cannot be sure how DEHP exposure resulted in this effect.   It is 
possible that DEHP was toxic to the recently implanted embryos and targeted females, causing 
more females to die in utero and resulting in fewer female pups than male pups in each litter.  
One would expect, though, that there would be an effect on overall litter size as well, which was 
not seen.  It is also possible that this treatment group had more pups per litter in utero, but the 
litter sizes normalized due to some post-implantation losses from DEHP exposure.  Examination 
of the uteri from F0 dams for implantation sites throughout pregnancy will be useful in future 
experiments to determine whether this was the case.  Interestingly, DEHP exposure did not alter 
sex ratio in F2 litters, suggesting that any effects of DEHP on sex ratio in F1 litters is not 
multigenerational. 
There is evidence that prenatal exposure to endocrine disrupting chemicals plays a role in 
influencing adult metabolism and body weight gain.  Typically, high exposure to EDCs with 
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estrogen-like activity increases the incidence of obesity [23].  In contrast, our data showed  that 
DEHP exposure resulted in a significant decrease in pup weights at PND 8 and PND 60, but did 
not affect overall prepubertal or postpubertal growth.  A difference in body weight caused by 
factors that occur prenatally is likely due to a change in gene expression during development.  
Expression of genes involved in metabolism and body fat deposition, such as peroxisome 
proliferator-activated receptors (PPARs), should be analyzed as a possible explanation for the 
observed DEHP-induced decrease in body weight.  Mono-ethyl-hexyl-phthalate (MEHP) a major 
bioactive metabolite of DEHP, has been recognized as an activator of PPARs, which are 
involved in lipid and carbohydrate metabolism [13, 24].  There may also be an interaction 
between estrogen levels and PPAR activity that influences obesity, so future analysis of estradiol 
levels in these mice will be helpful for determining the mechanism by which prenatal DEHP 
exposure reduces body weight in the pups [25].   
Our data also showed a significant reduction in mean liver weight at PND 8 for animals 
in the 200mg/kg/day group, and a trend towards reduction in liver weight for the two higher 
doses (500 and 750mg/kg/day) compared to controls.  This is interesting because exposure to 
DEHP is usually associated with an increase in liver weight due to activation of PPARs in the 
liver, resulting in liver cell hypertrophy and hyperplasia [14].  Like our unexpected results in 
overall body weight, the reduced liver weight could be a result of interaction with the PPARs 
differently than expected because of the selected doses and specific exposure window.  
According to a study performed by David et al., there is a possible threshold dose for PPAR-
induced liver effects in mice [26].  Future analysis of PPAR activity should be performed on 
liver samples collected to explain this phenomenon.   
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Prenatal DEHP exposure to 200µg/kg/day resulted in a significant increase in uterine 
weight at PND 21 and exposure to 750mg/kg/day resulted in a significant increase in uterine 
weight at PND 60 compared to controls.  Uterine weight increases in response to estrogen or 
estrogen-mimicking compounds [27], and this may occur through cross-talk between estrogen 
and PPARs [15].  An increase in uterine weight could be explained by an increase in PPAR 
activation related to an increase in estrogen synthesis by preantral and antral follicles present in 
the ovaries of mice at these two timepoints.  The increase in preantral follicle numbers we 
observed in PND 21 ovaries supports this explanation, but future studies should compare 
estrogen levels in control and DEHP-treated animals.  The possible relationship between prenatal 
DEHP exposure and the changes in tissue weights mediated through PPARs is summarized in 
Figure 17.  
While there were no statistically significant differences in days to pregnancy, F2 birth 
weight, F2 pups per litter, and F2 males to female sex ratio in the F1 females at any dose in 
comparison to control animals, DEHP exposure resulted in several breeding anomalies in F1 
females.  Approximately 14% of F1 females in the 750mg/kg/day group, 60% of F1 females in 
the 500mg/kg/day group, 33% of F1 females in the 200µg/kg/day group, and 25% of F1 females 
in the 20µg/kg/day group never got pregnant in the 3-month breeding period, even though they 
all were observed as having mated because of the presence of a vaginal plug.  This indicates that 
the mice were receptive to breeding, but pups were never born.  No significant weight gain was 
ever noted, either.  This means these females either did not produce viable oocytes for 
fertilization, or they experienced pre-implantation losses.  Other than the control females and the 
750mg/kg/day treated females, 15-25% of females in all other treatment groups took longer than 
5 days to get pregnant.  The time frame of 5 days until pregnancy was selected because the 
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average estrous cycle for mice (varying by strain) is 4-5 days [28], and mice are proficient 
breeders so most should become pregnant during the first cycle.  Thus, our data suggest that 
DEHP exposure may interfere with the ability of the F1 females to become pregnant or maintain 
a pregnancy.  Future studies should examine potential mechanisms for the DEHP-induced 
breeding abnormalities. 
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Conclusions: 
 This present study provides evidence that prenatal exposure to 200µg/kg/day DEHP 
affects the ratio of males to females in the F1 litters.  Prenatal exposure to 200mg/kg/day and 
750mg/kg/day reduces overall body weight at PND 8 and PND 60, respectively, though these 
shifts are not dramatic.  This may be explained by DEHP being metabolized to MEHP, which 
interacts with PPARs, ultimately altering metabolism.  Prenatal exposure to 200mg/kg/day 
DEHP reduces liver weight at PND 8, which may also be explained by MEHP interacting with 
PPARs.  Acute prenatal exposure to 200µg/kg/day and 750mg/kg/day DEHP results in 
significantly increased uterine weight at PND 21 and PND 60, respectively.  Uterine weight is an 
estrogen-dependent factor, and estrogen may be able to cross-talk with PPARs, which are being 
affected by DEHP.  Ovarian weight is significantly reduced at PND 21 following acute prenatal 
exposure to 20µg/kg/day DEHP.  At PND 8 ovarian morphology was unaffected, however, at 
PND 21, prenatal exposure to 200µg/kg/day and 500mg/kg/day DEHP increased the number of 
preantral follicles per ovary.  Finally, a number of breeding complications with DEHP exposure 
were observed in the F1 fertility analysis.  Further studies are required to understand the 
mechanism for these breeding complications.              
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Figures and Legends: 
Figure 1.  Effect of DEHP on F1 Litter Size 
 
 
 
 
 
 
 
 
 
At birth, the number of live pups in each litter was counted and compared in each treatment 
group.  Graph represents means ± SEM (n=5-17 dams/treatment group). 
 
 
21 
 
Figure 2.  Effect of DEHP on F1 Pup Birth Weight 
 
 
 
 
 
 
 
 
 
At birth, average weight of live pups was calculated as described in methods and 
compared in each treatment group.  Graph represents means ± SEM (n=5-18 
dams/treatment group). 
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Figure 3.  Effect of DEHP on F1 Anogenital Distance at PND21 
 
 
 
 
 
 
 
 
At PND 21, anogenital distance was measured in millimeters (mm) as described in 
methods and compared in each treatment group.  Graph represents means ± SEM (n=4-9 
dams/treatment group). 
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Figure 4.  Effect of DEHP on F1 Litter Sex Ratio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At birth, male to female ratio was calculated as described in methods and compared in 
each treatment group.  Graph represents means ± SEM (n=5-15 dams/treatment group).  
Asterisk (*) represents significant difference from vehicle control (p ≤ 0.05). 
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At each tissue collection, both uterine horns were removed and weighed at PND 8 (A), PND 
21 (B), and PND 60 (C).  The weights were compared in each treatment group.  Graph 
represents means ± SEM (n=2-16 dams/treatment group).  Asterisks (*) represent significant 
difference from vehicle control (p ≤ 0.05). 
Figure 8.  Effect of DEHP on Uterine Weight 
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Figure 9.  Effect of DEHP on Ovarian Weight 
At each tissue collection, both ovaries were removed and weighed at PND 21 (A), and PND 
60 (B).  The weights were compared in each treatment group.  Graph represents means ± SEM 
(n=2-16 dams/treatment group).  Asterisk (*) represents significant difference from vehicle 
control (p ≤ 0.05). 
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Figure 10.  Effect of DEHP on Pubertal Outcomes 
Age at vaginal opening (A), weight at vaginal opening (B), and age at first estrus (C) 
were determined and analyzed as described in methods.  The means were compared 
in each treatment group.  Graph represents means ± SEM (n=4-15 dams/treatment 
group). 
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Figure 11.  Effect of DEHP on Estrous Cyclicity 
After vaginal opening, estrous cyclicity was monitored for 30 days and the average 
cycle length for this time frame was determined as described in the methods.  The 
percent of time out of 30 days spent in each stage was calculated (A), as well as the 
average cycle length (B).  The means were compared in each treatment group.  
Graph represents means ± SEM (n=4-14 dams/treatment group). 
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Figure 12.  Mouse Ovarian Morphology 
B 
A 
The ovary is made up of primordial, primary, preantral, and antral follicles (A) and can be 
seen under a microscope at 20x magnification following staining using Weigert’s 
hematoxylin and picric acid – methyl blue (B). 
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Figure 13.  Effect of DEHP on Ovarian Morphology 
Ovaries collected from mice on PND 8 (A) and PND 21 (B) were subjected to histological 
evaluation for follicle number based on criteria described in the methods.  The graphs 
represent the mean total number of each follicle type present ± SEM (n=3-14 dams/treatment 
group). Asterisks (*) represent significant difference from vehicle control (p ≤ 0.05). 
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A 
B 
Figure 14.  Effect of DEHP on Apoptosis and Oocyte Health 
Ovaries from PND 21 females exposed to DEHP in utero displayed a high number 
of abnormal preantral and antral follicles containing apoptotic bodies (A) and 
unhealthy oocytes (B). 
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Treatment 
Never 
Produced 
a Litter 
Took longer 
than 5 days 
to get 
pregnant 
Lost some 
pups (2 or 
less) 
Lost all 
pups 
Control 7% 0% 7% 7% 
20µg/kg/day 25% 25% 0% 0% 
200µg/kg/day 33% 17% 0% 17% 
200mg/kg/day 0% 22% 11% 0% 
500mg/kg/day 60% 20% 0% 0% 
750mg/kg/day 14% 0% 14% 29% 
Figure 16.  F1 Breeding Complications Following DEHP Exposure (3 months) 
At 3 months of age, F1 females were bred to evaluate their fertility.  Breeding complications 
were observed and recorded as described in the methods.  Percentages shown are the number 
of females that displayed the abnormality divided by the total number of females in each 
treatment group. 
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Figure 17.  Possible relationship between DEHP and PPARs to alter tissue weights 
Previous studies have shown that DEHP, through its bioactive metabolite MEHP, alters 
expression and downstream activity of PPARs.  These receptors have also been known to 
interact with estrogen and estrogen receptor expression and activity.  Acting through these 
pathways could explain the observed changes in body, liver, uterine, and ovarian weight. 
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